Correlation Between Anebulo Pharmaceuticals and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Cadrenal Therapeutics,.
Diversification Opportunities for Anebulo Pharmaceuticals and Cadrenal Therapeutics,
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Anebulo and Cadrenal is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Cadrenal Therapeutics,
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Cadrenal Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 1.12 times less risky than Cadrenal Therapeutics,. The stock trades about -0.18 of its potential returns per unit of risk. The Cadrenal Therapeutics, Common is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 1,509 in Cadrenal Therapeutics, Common on August 28, 2024 and sell it today you would lose (153.00) from holding Cadrenal Therapeutics, Common or give up 10.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Cadrenal Therapeutics, |
Anebulo Pharmaceuticals and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Cadrenal Therapeutics,
The main advantage of trading using opposite Anebulo Pharmaceuticals and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. HCW Biologics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |